🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In clinical practice at the National centre for epilepsy (SSE) in Norway we...
Status
Unknown
Location
Rikshospitalet-Radiumhospitalet HF
Start Date
2007-05
Trial ID
NCT00393614
Treatments Being Tested
16 week trial assessing the efficacy, safety, and tolerability of levetirac...
Status
Completed
Location
Multiple Locations
Start Date
2004-04
Trial ID
NCT00160511
Treatments Being Tested
This study will provide information on the pharmacokinetics, safety and eff...
Status
Completed
Location
MUMC
Start Date
2014-08
Trial ID
NCT02421068
Seizures that arise in specific areas in the brain are called Localization ...
Status
Terminated
Location
Arkansas Children's Hospital
Start Date
2013-08
Trial ID
NCT01891890
Treatments Being Tested
Background. Anecdotal reports and uncontrolled studies have described an as...
Status
Unknown
Location
Clinica Neurologica Amaducci, Policlinico di Bari
Start Date
2012-05
Trial ID
NCT02429596
Treatments Being Tested
The part B of N01362 is to assess the pharmacokinetic profile of Levetirace...
Status
Completed
Location
1
Start Date
2012-05
Trial ID
NCT01618877
Treatments Being Tested
Unlike the first generation antiepileptic medications, newer drugs for epil...
Status
Completed
Location
Severance hospital
Start Date
2011-09
Trial ID
NCT02208492
Treatments Being Tested
The purpose of this study is to assess the usefulness of a medication (Leve...
Status
Completed
Location
Rhode Island Hospital Body Dysmorphic Disorder Program
Start Date
2004-12
Trial ID
NCT00265109
Treatments Being Tested
This study is planned to evaluate the safety and efficacy of L059 (levetira...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00367432
Treatments Being Tested
The purpose of the study is to evaluate the pharmacokinetics (PK) of brivar...
Status
Terminated
Location
N01349 204
Start Date
2019-05-07
Trial ID
NCT03325439
Treatments Being Tested